Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
Thank you for joining us on Saturday for the 2023 Targeted Therapies in Lung Cancer Patient Forum!
The full unedited versions of the 2023 Targeted Therapies in Lung Cancer Patient Forum presentations from the Mainstage and Second Stage, are now available OnDemand. These topics will be edited and offered as shorter videos in the coming weeks.
The full videos are available on our YouTube channel via this link: https://youtube.com/playlist?list=PLWsyUmdjLXhG4km7yALHmLjQSeUQg-36x
ALL Available Slides are found under 'Documents Available for Download' on the left sidebar of the event platform. If any new ones are made available we will add them there!
A huge thank you to our sponsors! #gehealthcare #ExactSciences #janssen #takedaoncology #lilly #genentech #Bristolmyerssquibb #bms #Mirati
To ask a question, visit https://cancergrace.org/forum
Please feel free to offer comments and raise questions in our
discussion forums.
Hi Stan! So good to hear from you. I'm sorry for the late response. I too have been out of town with family and missed your post, probably because I was...
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
An antibody–drug conjugate (ADC) works a bit like a Trojan horse. It has three main components: